07 November 2023>: Articles
Neoadjuvant Lorlatinib Induces Pathological Complete Response in Advanced ALK-Positive Lung Cancer: A Case Report
Unusual or unexpected effect of treatment, Unexpected drug reaction
Jie Li * , Junwei Liu * , Guqin Zhang B , Weidong Hu G , Xianguo Wang B , Jun Liu A*DOI: 10.12659/AJCR.942150
Am J Case Rep 2023; 24:e942150
Figure 4. Schematic of timeline with therapy and disease status.